| Date | Time | Source | Headline | Symbol | Company |
| 05/30/2024 | 9:12AM | Edgar (US Regulatory) | Form 15-12G - Securities registration termination [Section 12(g)] | NASDAQ:ALPN | Alpine Immune Sciences Inc |
| 05/24/2024 | 12:15AM | Edgar (US Regulatory) | Form EFFECT - Notice of Effectiveness | NASDAQ:ALPN | Alpine Immune Sciences Inc |
| 05/24/2024 | 12:15AM | Edgar (US Regulatory) | Form EFFECT - Notice of Effectiveness | NASDAQ:ALPN | Alpine Immune Sciences Inc |
| 05/21/2024 | 4:49PM | Edgar (US Regulatory) | Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] | NASDAQ:ALPN | Alpine Immune Sciences Inc |
| 05/21/2024 | 10:21AM | Edgar (US Regulatory) | Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] | NASDAQ:ALPN | Alpine Immune Sciences Inc |
| 05/20/2024 | 8:13PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:ALPN | Alpine Immune Sciences Inc |
| 05/20/2024 | 8:12PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:ALPN | Alpine Immune Sciences Inc |
| 05/20/2024 | 8:05PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:ALPN | Alpine Immune Sciences Inc |
| 05/20/2024 | 8:03PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:ALPN | Alpine Immune Sciences Inc |
| 05/20/2024 | 8:02PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:ALPN | Alpine Immune Sciences Inc |
| 05/20/2024 | 8:53AM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:ALPN | Alpine Immune Sciences Inc |
| 05/20/2024 | 8:52AM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:ALPN | Alpine Immune Sciences Inc |
| 05/20/2024 | 8:51AM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:ALPN | Alpine Immune Sciences Inc |
| 05/20/2024 | 8:50AM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:ALPN | Alpine Immune Sciences Inc |
| 05/20/2024 | 8:50AM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:ALPN | Alpine Immune Sciences Inc |
| 05/20/2024 | 8:49AM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:ALPN | Alpine Immune Sciences Inc |
| 05/20/2024 | 8:49AM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:ALPN | Alpine Immune Sciences Inc |
| 05/20/2024 | 8:48AM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:ALPN | Alpine Immune Sciences Inc |
| 05/20/2024 | 8:47AM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:ALPN | Alpine Immune Sciences Inc |
| 05/20/2024 | 8:47AM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:ALPN | Alpine Immune Sciences Inc |
| 05/20/2024 | 8:46AM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:ALPN | Alpine Immune Sciences Inc |
| 05/20/2024 | 8:45AM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:ALPN | Alpine Immune Sciences Inc |
| 05/20/2024 | 8:45AM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:ALPN | Alpine Immune Sciences Inc |
| 05/20/2024 | 8:44AM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:ALPN | Alpine Immune Sciences Inc |
| 05/20/2024 | 8:43AM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:ALPN | Alpine Immune Sciences Inc |
| 05/20/2024 | 8:43AM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:ALPN | Alpine Immune Sciences Inc |
| 05/20/2024 | 8:42AM | Edgar (US Regulatory) | Form POS AM - Post-Effective amendments for registration statement | NASDAQ:ALPN | Alpine Immune Sciences Inc |
| 05/20/2024 | 8:41AM | Edgar (US Regulatory) | Form POS AM - Post-Effective amendments for registration statement | NASDAQ:ALPN | Alpine Immune Sciences Inc |
| 05/20/2024 | 8:38AM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:ALPN | Alpine Immune Sciences Inc |
| 05/20/2024 | 8:27AM | Edgar (US Regulatory) | Form SC 14D9/A - Solicitation, recommendation statements: [Amend] | NASDAQ:ALPN | Alpine Immune Sciences Inc |